191 related articles for article (PubMed ID: 31661010)
1. Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma.
Schuhmacher P; Kim E; Hahn F; Sekula P; Jilg CA; Leiber C; Neumann HP; Schultze-Seemann W; Walz G; Zschiedrich S
Orphanet J Rare Dis; 2019 Oct; 14(1):235. PubMed ID: 31661010
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
[TBL] [Abstract][Full Text] [Related]
3. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
Beroukhim R; Brunet JP; Di Napoli A; Mertz KD; Seeley A; Pires MM; Linhart D; Worrell RA; Moch H; Rubin MA; Sellers WR; Meyerson M; Linehan WM; Kaelin WG; Signoretti S
Cancer Res; 2009 Jun; 69(11):4674-81. PubMed ID: 19470766
[TBL] [Abstract][Full Text] [Related]
4. Clear Cell Renal Cell Carcinoma Growth Correlates with Baseline Diffusion-weighted MRI in Von Hippel-Lindau Disease.
Farhadi F; Nikpanah M; Paschall AK; Shafiei A; Tadayoni A; Ball MW; Linehan WM; Jones EC; Malayeri AA
Radiology; 2020 Jun; 295(3):583-590. PubMed ID: 32255415
[TBL] [Abstract][Full Text] [Related]
5. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients.
Thompson LDR; Magliocca KR; Andreasen S; Kiss K; Rooper L; Stelow E; Wenig BM; Bishop JA
Head Neck Pathol; 2019 Sep; 13(3):355-363. PubMed ID: 30291511
[TBL] [Abstract][Full Text] [Related]
6. A case of von Hippel-Lindau disease with bilateral pheochromocytoma, renal cell carcinoma, pelvic tumor, spinal hemangioblastoma and primary hyperparathyroidism.
Arao T; Okada Y; Tanikawa T; Inatomi H; Shuin T; Fujihira T; Yamashita H; Tanaka Y
Endocr J; 2002 Apr; 49(2):181-8. PubMed ID: 12081237
[TBL] [Abstract][Full Text] [Related]
7. A Case of von Hippel-Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas.
Heo SJ; Lee CK; Hahn KY; Kim G; Hur H; Choi SH; Han KS; Cho A; Jung M
Cancer Res Treat; 2016 Jan; 48(1):409-14. PubMed ID: 25715769
[TBL] [Abstract][Full Text] [Related]
8. Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α.
Fan Y; Li H; Ma X; Gao Y; Bao X; Du Q; Ma M; Liu K; Yao Y; Huang Q; Zhang Y; Zhang X
Oncotarget; 2016 Apr; 7(14):18280-94. PubMed ID: 26943772
[TBL] [Abstract][Full Text] [Related]
9. Natural history of Von Hippel-Lindau disease-associated and sporadic clear cell renal cell carcinoma: a comparative study.
Wang J; Zhang L; Qiu J; Li Z; Wu Y; Zhang C; Yao L; Gong K; Li X; Zhou L
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2631-2641. PubMed ID: 34709473
[TBL] [Abstract][Full Text] [Related]
10. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease.
Duffey BG; Choyke PL; Glenn G; Grubb RL; Venzon D; Linehan WM; Walther MM
J Urol; 2004 Jul; 172(1):63-5. PubMed ID: 15201738
[TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment of renal-cell carcinoma in von Hippel-Lindau disease].
Uscanga-Yépez J; Rodríguez-Covarrubias F; Morales J; Granados J; Gabilondo-Navarro F
Rev Invest Clin; 2013; 65(4):318-22. PubMed ID: 24304732
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma.
Neumann HP; Bender BU; Berger DP; Laubenberger J; Schultze-Seemann W; Wetterauer U; Ferstl FJ; Herbst EW; Schwarzkopf G; Hes FJ; Lips CJ; Lamiell JM; Masek O; Riegler P; Mueller B; Glavac D; Brauch H
J Urol; 1998 Oct; 160(4):1248-54. PubMed ID: 9751329
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
[TBL] [Abstract][Full Text] [Related]
14. An MRI-based radiomics model to predict clear cell renal cell carcinoma growth rate classes in patients with von Hippel-Lindau syndrome.
Anari PY; Lay N; Gopal N; Chaurasia A; Samimi S; Harmon S; Firouzabadi FD; Merino MJ; Wakim P; Turkbey E; Jones EC; Ball MW; Turkbey B; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2022 Oct; 47(10):3554-3562. PubMed ID: 35869307
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
[TBL] [Abstract][Full Text] [Related]
16. [Renal cell carcinoma in von Hippel-Lindau disease. Nephron sparing surgery.].
Urbieta Anza A; Llarena Ibarguren R; Tomás Zabala Egurrola JA; Gutierrez Zurimendi G; Iturregui Del Pozo AM; Arruza Echevarria A
Arch Esp Urol; 2018 Nov; 71(9):757-764. PubMed ID: 30403378
[TBL] [Abstract][Full Text] [Related]
17. [Two-stage nephron-sparing surgery for bilateral T2 renal cell carcinoma and von Hippel-Lindau disease: a case report].
Iguchi R; Kanematsu A; Nakamura E; Shimizu T; Watanabe J; Soda T; Kamba T; Yoshimura K; Nishiyama H; Kamoto T; Ogawa O
Hinyokika Kiyo; 2009 Aug; 55(8):483-5. PubMed ID: 19764533
[TBL] [Abstract][Full Text] [Related]
18. Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel-Lindau disease.
Hoang MP; Hruban RH; Albores-Saavedra J
Am J Surg Pathol; 2001 May; 25(5):602-9. PubMed ID: 11342771
[TBL] [Abstract][Full Text] [Related]
19. VHL gene alterations in Italian patients with isolated renal cell carcinomas.
Muscarella LA; D'Agruma L; la Torre A; Gigante M; Coco M; Parrella P; Battaglia M; Carrieri G; Carella M; Zelante L; Fazio VM; Gesualdo L; Ranieri E
Int J Biol Markers; 2013 Jun; 28(2):208-15. PubMed ID: 23558940
[TBL] [Abstract][Full Text] [Related]
20. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery.
Walther MM; Choyke PL; Glenn G; Lyne JC; Rayford W; Venzon D; Linehan WM
J Urol; 1999 May; 161(5):1475-9. PubMed ID: 10210376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]